At the annual American Diabetes Association conference this June (held entirely online this year), lots of research was presented, and as always, a slew of new tech and product news was announced.
Here are some of the highlights!
Two new types of insulin were presented: Eli Lilly's ultra-rapid Lyumjev and Mylan and Biocon's Semglee basal insulin.
Medtronic has collected pivotal trial data for its upcoming Minimed 780G (Advanced Hybrid Closed Loop System), in preparation for filing for FDA approval.
Medtronic's 770G has already been filed with the FDA and is considered the "stop-gap" between the 670G and 780G. Read more about Medtronic's tech developments here.
Tandem announced FDA approval of its Control-IQ system for children ages six and over.
The closed loop OmniPod 5 is expected in 2021.
The Dexcom G6 Pro, a clinically focused, professional version of its Dexcom G6 CGM is slated to start shipping to clinics and physicians' offices this month.
Learn more about all of the details of the conference here.